Background and significance COPD exacerbations are associated with significant morbidity, mortality, and substantial healthcare cost. The eosinophilic phenotype of COPD has been demonstrated to respond better to corticosteroids thus providing better clinical outcomes. This review aims to elucidate further the correlation between blood eosinophilia and outcomes in hospitalised patients with COPD exacerbations.
Methods We systematically searched published and unpublished literature for potential studies that fulfilled our eligibility criteria. Inclusion criteria include any cohort (prospective or retrospective), case-control or randomised trials that looked into the association of blood eosinophilia and outcomes in hospitalised COPD exacerbation patients. The primary study outcome was length of hospitalisation; other outcomes include readmission and mortality rate within 1 year, in-patient mortality, and need for mechanical ventilation. An extensive eligibility, methodological and risk of bias assessments were performed independently by two authors adhering to the MOOSE and Cochrane standards.
Results Six studies, with a total of 7293 patients, were included in the review. Five are retrospective cohorts and one is a retrospective analysis of a subgroup of a randomised trial. Patients with blood eosinophilia had significantly shorter hospital stay compared to non-eosinophilic patients (mean difference 0.68 days [95% CI: 1.09, 0.27]). Eosinophilic patients had significantly less frequent readmissions (odds ratio/OR 0.69 [95% CI: 0.55, 0.87]) but there was no statistically significant difference in the 1-year mortality rate (OR 0.88 [95% CI: 0.73, 1.06]). Analysis showed a trend toward lower in-patient mortality among eosinophilic patients, although this difference is not statistically significant (OR 0.53 [95% CI: 0.27, 1.05]). Furthermore, COPD patients with eosinophilia had significantly less need for mechanical ventilation during an exacerbation (OR 0.56 [95% CI: 0.35, 0.89]). Only the primary outcome was significantly heterogenous.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.